- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
- IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
- IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
- IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
- IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
- IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events
More ▼
Key statistics
As of last trade IDEAYA Biosciences Inc (IDYA:NSQ) traded at 39.22, -17.84% below its 52-week high of 47.74, set on Feb 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 38.90 |
---|---|
High | 39.27 |
Low | 38.11 |
Bid | 39.15 |
Offer | 39.26 |
Previous close | 38.62 |
Average volume | 687.52k |
---|---|
Shares outstanding | 74.56m |
Free float | 73.83m |
P/E (TTM) | -- |
Market cap | 2.88bn USD |
EPS (TTM) | -1.96 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 15:21 BST.
More ▼